In the latest episode of the #ParexelBiotech podcast series, “De-Risking Drug Development,” our host, Paul Bridges, and colleagues focus on critical decision points in phases IIb & III that can ultimately determine the success of your product. Join Sangeeta Budhia, Sinan B. Sarac (MD, MSc, PhD), and Amy Pace as they discuss how to accelerate development and opportunities to differentiate your product through innovative and adaptive trial designs. Learn about the importance of integrated evidence planning and the critical role of early value story development alongside target product profile (TPP) planning. Mitigate development risks and stand out among competitors by planning ahead. Listen here: https://lnkd.in/g9Kt5hGA #Biotech #TrialDesign #ClinicalDevelopment
Parexel’s Post
More Relevant Posts
-
Consultative Development Manager Parexel Biotech at Parexel #neverstopbioteching #clinicaltrials #patientsfirst #globalexpertise
In the latest episode of the #ParexelBiotech podcast series, “De-Risking Drug Development,” our host, Paul Bridges, and colleagues focus on critical decision points in phases IIb & III that can ultimately determine the success of your product. Join Sangeeta Budhia, Sinan Sarac, and Amy Pace as they discuss how to accelerate development and opportunities to differentiate your product through innovative and adaptive trial designs. Learn about the importance of integrated evidence planning and the critical role of early value story development alongside target product profile (TPP) planning. Mitigate development risks and stand out among competitors by planning ahead. Listen here: https://lnkd.in/drgWASg5 #Biotech #TrialDesign #ClinicalDevelopment
-
Business Development Manager @ Parexel | Sales Target Management | French, Spanish, English speaker
In the latest episode of the #ParexelBiotech podcast series, “De-Risking Drug Development,” our host, Paul Bridges, and colleagues focus on critical decision points in phases IIb & III that can ultimately determine the success of your product. Join Sangeeta Budhia, Sinan Sarac, and Amy Pace as they discuss how to accelerate development and opportunities to differentiate your product through innovative and adaptive trial designs. Learn about the importance of integrated evidence planning and the critical role of early value story development alongside target product profile (TPP) planning. Mitigate development risks and stand out among competitors by planning ahead. Listen here: https://lnkd.in/eiutsSwF #Biotech #TrialDesign #ClinicalDevelopment
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept :: Parexel
share.parexel.social
-
In the latest episode of the #ParexelBiotech podcast series, “De-Risking Drug Development,” our host, Paul Bridges, and colleagues focus on critical decision points in phases IIb & III that can ultimately determine the success of your product. Join Sangeeta Budhia, Sinan Sarac, and Amy Pace as they discuss how to accelerate development and opportunities to differentiate your product through innovative and adaptive trial designs. Learn about the importance of integrated evidence planning and the critical role of early value story development alongside target product profile (TPP) planning. Mitigate development risks and stand out among competitors by planning ahead. Listen here: https://lnkd.in/eTbgnSXb #Biotech #TrialDesign #ClinicalDevelopment
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept :: Parexel
share.parexel.social
-
In the latest episode of the #ParexelBiotech podcast series, “De-Risking Drug Development,” our host, Paul Bridges, and colleagues focus on critical decision points in phases IIb & III that can ultimately determine the success of your product. Join Sangeeta Budhia, Sinan Sarac, and Amy Pace as they discuss how to accelerate development and opportunities to differentiate your product through innovative and adaptive trial designs. Learn about the importance of integrated evidence planning and the critical role of early value story development alongside target product profile (TPP) planning. Mitigate development risks and stand out among competitors by planning ahead. Listen here: https://lnkd.in/gm4P23Ex #Biotech #TrialDesign #ClinicalDevelopment
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept :: Parexel
share.parexel.social
-
In the latest episode of the #ParexelBiotech podcast series, “De-Risking Drug Development,” our host, Paul Bridges, and colleagues focus on critical decision points in phases IIb & III that can ultimately determine the success of your product. Join Sangeeta Budhia, Sinan Sarac, and Amy Pace as they discuss how to accelerate development and opportunities to differentiate your product through innovative and adaptive trial designs. Learn about the importance of integrated evidence planning and the critical role of early value story development alongside target product profile (TPP) planning. Mitigate development risks and stand out among competitors by planning ahead. Listen here: #Biotech #TrialDesign #ClinicalDevelopment
De-risking Drug Development | Episode 3: Plan how to get to market quickly, post proof-of-concept :: Parexel
share.parexel.social
-
Fractional expertise is powerful!
I help biotech leaders reduce manufacturing costs to make lifesaving therapies accessible to more patients worldwide | Strategic Advisor | CMC Development | Project Management
Biotech innovators, ready to supercharge your drug development process? Our latest Smart Biotech Scientist podcast episode unveils a game-changing strategy: "The Swiss Army Knife of Biotech: Unleashing the Power of Fractional Expertise" Discover how fractional CTOs are revolutionizing the biotech landscape: - Learn from Michael Jordan's playbook for achieving greatness - Explore how part-time expertise can solve full-time challenges - Find out how to accelerate your path to market This episode is your guide to: ✓ Slashing development timelines ✓ Mitigating risks with seasoned insights ✓ Gaining a competitive edge without breaking the bank Keep your biotech venture from playing solo. It's time to assemble your dream team of on-demand experts! Have you considered bringing fractional expertise into your biotech team? Share your thoughts! 👇 #Biotech #DrugDevelopment #Innovation #CTO #Bioprocessing
-
-
QA/Regulatory/Engineering Consulting Solutions | Medical Device-Biotech-Pharma | Podcaster | Author | Speaker | Cultural Architect | Strategic Encourager
Excited to announce the release of Episode 23 of BioTalk Unzipped! 🎙️ In this second half of our fascinating conversation with Scott Ogle, CEO of TruLab, Real-Time Technology for Clinical Trial Oversight, Dr. Chad Briscoe and I dive into key trends shaping the biotech industry and beyond. 🌐💡 💼 We explore surprising parallels between the banking and pharma industries, the game-changing role of digital twinning in clinical trials, and the evolving landscape of biotech funding. Scott also shares personal insights on leadership, mentorship, and the impact of the Inflation Reduction Act on pharma innovation. This episode is packed with valuable takeaways for anyone navigating the world of biotech and drug development. 🔍 Topics include: ✔️Biotech funding and macroeconomic factors ✔️How AI-powered digital twinning could revolutionize clinical trials ✔️The importance of maintaining data integrity in decentralized trials ✔️The influence of family and mentorship on leadership Scott is a very engaging and genuine guy whom I think you'll enjoy. Don't miss this episode filled with practical advice, bold insights, and a fresh perspective on innovation in pharma! 🎧 The Episode: https://lnkd.in/gUg3EZfV #BioTalkUnzipped #Biotech #PharmaInnovation #ClinicalTrials #Leadership #Mentorship #BiotechFunding #Podcast
-
"There is a better way for large pharma to support innovation" - Stella K. Vnook, CEO Likarda This is so interesting! Stella K. Vnook shares her fascinating perspective on the relationship between big pharma and small biotech. She highlights what each can learn from the other and how a change in mindset could unlock tremendous value. Stay tuned for the full episode 9 release tomorrow! The BioHub Podcast🚀 #TheBioHub #Podcast #Biotech #Innovation #Pharma #SmallBiotech #StellaVnook #Collaboration #Healthcare #FutureOfMedicine
-
Host, Business of Biotech Podcast and Chief Editor, Bioprocess Online, Life Science Connect
What a fascinating conversation on applications for #artificialintelligence in #biotech/techbio with Foresite Labs' Vik Bajaj. We cover the justification for his part in a $1B startup called Xaira Therapeutics, its place on the widening AI-empowered bio landscape, data limitations and how they're solved, and so much more. Tune into the videocast here, or listen and subscribe wherever you get your podcasts. https://lnkd.in/efb-bMZB Life Science Connect Bioprocess Online Life Science Leader
-
New podcast: How technology is impacting drug discovery This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI is critical to solving new complexities in drug discovery and The push towards lab automation in biopharma. https://lnkd.in/ewtXzgUk #DrugDiscovery #Biopharma #LabAutomation
-
